News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,463 Results
Type
Article (39211)
Company Profile (282)
Press Release (649970)
Section
Business (203936)
Career Advice (1999)
Deals (35384)
Drug Delivery (89)
Drug Development (80873)
Employer Resources (168)
FDA (16110)
Job Trends (14814)
News (344705)
Policy (32453)
Tag
Academia (2530)
Alliances (49245)
Alzheimer's disease (1283)
Approvals (16071)
Artificial intelligence (159)
Bankruptcy (354)
Best Places to Work (11596)
Biotechnology (199)
Breast cancer (201)
Cancer (1483)
Cardiovascular disease (119)
Career advice (1665)
Cell therapy (306)
Clinical research (64889)
Collaboration (547)
Compensation (301)
COVID-19 (2546)
C-suite (128)
Data (1451)
Diabetes (185)
Diagnostics (6187)
Earnings (85006)
Employer resources (146)
Events (110312)
Executive appointments (459)
FDA (16860)
Funding (497)
Gene therapy (212)
GLP-1 (614)
Government (4336)
Healthcare (18735)
Infectious disease (2642)
Inflammatory bowel disease (112)
Interviews (309)
IPO (16376)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7866)
Lung cancer (220)
Manufacturing (212)
Medical device (13225)
Medtech (13230)
Mergers & acquisitions (19244)
Metabolic disorders (486)
Neuroscience (1634)
NextGen: Class of 2025 (6504)
Non-profit (4471)
Northern California (1843)
Obesity (277)
Opinion (185)
Parkinson's disease (105)
Patents (130)
People (56596)
Phase I (20194)
Phase II (28578)
Phase III (21292)
Pipeline (602)
Postmarket research (2561)
Preclinical (8551)
Radiopharmaceuticals (238)
Rare diseases (279)
Real estate (5893)
Regulatory (21757)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1587)
Startups (3565)
United States (16339)
Vaccines (571)
Weight loss (191)
Date
Today (188)
Last 7 days (905)
Last 30 days (2143)
Last 365 days (35037)
2025 (1312)
2024 (35252)
2023 (40077)
2022 (51174)
2021 (55711)
2020 (54086)
2019 (46541)
2018 (35020)
2017 (32110)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (202)
Asia (37362)
Australia (6099)
California (4164)
Canada (1528)
China (352)
Colorado (188)
Connecticut (199)
Europe (80021)
Florida (586)
Georgia (141)
Illinois (409)
Indiana (237)
Maryland (672)
Massachusetts (3226)
Michigan (180)
Minnesota (312)
New Jersey (1168)
New York (1184)
North Carolina (777)
Northern California (1843)
Ohio (150)
Pennsylvania (984)
South America (1093)
Southern California (1587)
Texas (599)
Utah (118)
Washington State (425)
689,463 Results for "verastem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 8, 2025
January 9, 2025
·
1 min read
Press Releases
Verastem Oncology to Participate in Upcoming Investor Conferences
October 31, 2024
·
1 min read
Deals
Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes
Verastem Oncology today announced that in connection with the 2024 Russell U.S. Indexes annual reconstitution, the company will be added to the Russell 3000 ® and Russell Microcap ® Indexes, effective at the open of U.S. equity markets today, Monday, July 1, 2024.
July 1, 2024
·
9 min read
Press Releases
Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024
·
1 min read
Press Releases
Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer in Mid-2025
January 13, 2025
·
14 min read
Press Releases
Verastem Oncology Exercises Option Early to License VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, from GenFleet Therapeutics and Provides Preliminary Clinical Update on Phase 1 Study in China
January 14, 2025
·
11 min read
Press Releases
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
December 31, 2024
·
13 min read
Press Releases
Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
December 18, 2024
·
13 min read
Genetown
Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Verastem Oncology announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024 at 3:35 pm EDT.
May 7, 2024
·
1 min read
Press Releases
Verastem Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
November 7, 2024
·
19 min read
1 of 68,947
Next
